Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: Effects on glycoprotein incorporation and infectivity

Journal of Virology

Volumn 74, Issue 24, 2000, Pages 11717-11723

  Piller, S C ^a   Dubay, J W ^a   Derdeyn, C A ^a   Hunter, E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLYCOPROTEIN GP 41;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOPLASM; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MOTIF; REGULATORY MECHANISM; VIRION; VIRUS INFECTIVITY;

AMINO ACID SEQUENCE; CONSERVED SEQUENCE; DNA MUTATIONAL ANALYSIS; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; VIRULENCE;

EID: 0034467955     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.24.11717-11723.2000     Document Type: Article

References (38)

1. Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41
2. HIV-cell fusion. The viral mousetrap
3. Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1
4. HIV entry and its inhibition
5. High-efficiency transformation of mammalian cells by plasmid DNA
6. Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity
7. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes
8. A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes
9. Direct interaction between the envelope and matrix proteins of HIV-1
10. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein
11. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity
12. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity
13. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions
14. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix
15. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins
16. The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes
17. gp41, a multifunctional protein involved in HIV entry and pathogenesis
18. Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin
19. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
20. Effect of the conformation of a peptide from gp41 on binding and domain formation in model membranes
21. Site-specific deuterium order parameters and membrane-bound behavior of a peptide fragment from the intracellular domain of HIV-1 gp41
22. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1
23. Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity
24. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains
25. Alterations in cell membrane permeability by the lentivirus lyric peptide (LLP-1) of HIV-1 transmembrane protein
26. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions
27. Expression of HIV-1 envelope glycoprotein alters cellular calmodulin
28. Analysis of a human immunodeficiency virus type 1 isolate carrying a truncated transmembrane glycoprotein
29. Shorter size of transmembrane glycoprotein of an HIV-1 isolate
30. Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins
31. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein
32. Calmodulin-binding function of LLP segments from the HIV type 1 transmembrane protein is conserved among natural sequence variants
33. Interaction of a basic amphipathic peptide from the carboxyterminal part of the HIV envelope protein gp41 with negatively charged lipid surfaces
34. Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein
35. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product
36. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160
37. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions
38. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions